Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.15 +0.07 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.08 | 52 Week High | $45.34 | |||
| Open | $4.08 | 52 Week Low | $15.92 | |||
| Day High | $4.29 | P/E | 1.78 | |||
| Day Low | $4.04 | EPS | $2.33 | |||
| Volume | 1,860,267 | |||||
